Prostatype Genomics AB (publ) (STO:PROGEN)
Sweden · Delayed Price · Currency is SEK 0.4710
-0.0020 (-0.42%)
Jun 26, 2026, 5:15 PM CET
Prostatype Genomics AB Revenue
In the year 2025, Prostatype Genomics AB had annual revenue of 594.00K SEK, down -69.03%. Prostatype Genomics AB had revenue of 348.00K in the half year ending December 31, 2025, a decrease of -86.95%.
Revenue
594.00K
Revenue Growth
-69.03%
P/S Ratio
46.93
Revenue / Employee
84.86K
Employees
7
Market Cap
27.88M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 594.00K | -1.32M | -69.03% |
| Dec 31, 2024 | 1.92M | -1.81M | -48.55% |
| Dec 31, 2023 | 3.73M | 3.05M | 445.83% |
| Dec 31, 2022 | 683.00K | -1.83M | -72.78% |
| Dec 31, 2021 | 2.51M | -498.13K | -16.56% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Getinge AB | 34.09B |
| Swedish Orphan Biovitrum AB | 28.96B |
| Medicover AB | 26.60B |
| Sectra AB | 3.64B |
| Magle Chemoswed Holding AB | 273.25M |
| Aino Health AB | 24.27M |
| Perpetua Medical AB | 16.31M |
| SpectraCure AB | -101.00K |
Prostatype Genomics AB News
- 4 months ago - Prostatype Genomics AB Quarterly report: Q4 2025 - Filings
- 4 months ago - Prostatype Genomics AB Annual report: Q4 2025 - Filings
- 7 months ago - Prostatype Genomics AB Transcript: Life Science Summit 2025 - Transcripts
- 1 year ago - Prostatype Genomics AB Quarterly report: Q2 2025 - Filings